Tectonic Therapeutic
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
490 Arsenal Way Ste 210, Watertown, Mass...Phone Number
(617) 914-8420Website
www.tectonictx.comRevenue
-Stock Symbol
TECXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Tectonic Therapeutic
Tectonic is a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs). Tectonic was co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School.Explore more
Tectonic Therapeutic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tectonic Therapeutic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Tectonic Therapeutic is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Tectonic Therapeutic
Check if Tectonic Therapeutic has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tectonic Therapeutic has new funding data
Tectonic Therapeutic, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Tectonic Therapeutic recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Tectonic Therapeutic launches new products
Click to see if Tectonic Therapeutic had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Tectonic Therapeutic
Compare insights from companies similar to Tectonic Therapeutic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tectonic Therapeutic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tectonic Therapeutic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tectonic Therapeutic.
Tectonic Therapeutic financials insights
Gather financial insights about Tectonic Therapeutic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$80M
Tectonic Therapeutic Tech Stack
A closer look at the technologies used by Tectonic Therapeutic
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Person-Based
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Share Placement, Finance
Tectonic Therapeutic News & Media
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic” or the “Company”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced financial results for the first quarter ended March 31, 2026, and provided an overview of recent business highlights.Tectonic Therapeutic CMO sells 1,065 shares at $30 | TECX Insider Trading - Stock Titan
Chief Medical Officer Marcella K. Ruddy sold 1,065 TECX shares at $30 under a Rule 10b5-1 plan, retaining 67,682 shares after the pre-arranged open-market transaction.Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed Jessica Chutter to its Board of Directors, effective June 8, 2026.Tectonic Therapeutic (TECX) CMO sells 1000 shares in planned trade - Stock Titan
Tectonic Therapeutic Chief Medical Officer Marcella K. Ruddy sold 1,000 TECX shares at $31.05 under a Rule 10b5-1 plan, retaining 68,747 shares afterward.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Tectonic Therapeutic
Sign Up For FreeTo access detailed company insights
Tectonic is a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs). Tectonic was co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School.... Read More
